{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:32:44Z","timestamp":1787239964905,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathol. Oncol. Res."],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1007\/bf02893442","type":"journal-article","created":{"date-parts":[[2009,1,9]],"date-time":"2009-01-09T18:08:23Z","timestamp":1231524503000},"page":"57-62","source":"Crossref","is-referenced-by-count":20,"title":["Prevention and treatment of hyperuricemia with rasburicase in children with leukemia and non-Hodgkin\u2019s lymphoma"],"prefix":"10.1007","volume":"13","author":[{"given":"Imre","family":"R\u00e9nyi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"B\u00e1rdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erzs\u00e9bet","family":"Udvardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Kov\u00e1cs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Bartyik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pal","family":"Kajt\u00e1r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e9ter","family":"Mas\u00e1t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiman","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Gal\u00e1ntai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csongor","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02893442_CR1","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1182\/blood.V97.10.2998","volume":"97","author":"SC Goldman","year":"2001","unstructured":"Goldman SC, Holcenberg JS, Finkleinstein JZ, et al: A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97: 2998\u20133003, 2001","journal-title":"Blood"},{"key":"BF02893442_CR2","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1038\/sj.leu.2400850","volume":"11","author":"CH Pui","year":"1997","unstructured":"Pui CH, Relling MV, Lascombes F, et al: Urate oxidase in prevention and treatment of hyperuricemia associated with lymphoid malignancies. Leukemia 11: 1813\u20131816, 1997","journal-title":"Leukemia"},{"key":"BF02893442_CR3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1200\/JCO.2001.19.3.697","volume":"19","author":"CH Pui","year":"2001","unstructured":"Pui CH, Mahmoud HH, Wiley JM, et al: Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 19: 697\u2013704, 2001","journal-title":"J Clin Oncol"},{"key":"BF02893442_CR4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cncr.11612","volume":"98","author":"A Bosly","year":"2003","unstructured":"Bosly A, Sonet A, Pinkerton CR, et al: Rasburicase (recombinant urate oxidase) for the management hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer 98: 1048\u20131054, 2003","journal-title":"Cancer"},{"key":"BF02893442_CR5","first-page":"80","volume":"147","author":"A Pession","year":"2005","unstructured":"Pession A, Barbieri E: Treatment and prevention of tumor lysis syndrome in children. Experience of Associazione Italiana Ematologia Oncologia Pediatrica. Contrib Nephrol 147:80\u201392, 2005","journal-title":"Contrib Nephrol"},{"key":"BF02893442_CR6","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.leu.2401973","volume":"14","author":"M Schrappe","year":"2000","unstructured":"Schrappe M, Reiter A, Zimmermann M, et al: Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995, Berlin-Frankfurt-Munster. Leukemia 14: 2205\u20132222, 2000","journal-title":"Leukemia"},{"key":"BF02893442_CR7","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1200\/JCO.1995.13.2.359","volume":"113","author":"A Reiter","year":"1995","unstructured":"Reiter A, Schrappe M, Parwaresch R, et al: Non-Hodgkin\u2019s lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage \u2014 a report of the Berlin-Frankfurt-Munster Group. Clin Oncol 113: 359\u2013372, 1995","journal-title":"Clin Oncol"},{"key":"BF02893442_CR8","first-page":"202","volume":"7","author":"G Masera","year":"1985","unstructured":"Masera G, Jankovic M, Zurlo MG, et al: Urate-oxidase prophylaxis of uric acid-induced renal damage in childhood leukemia. J Pediatr 7: 202\u2013204, 1985","journal-title":"J Pediatr"},{"key":"BF02893442_CR9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-9343(80)90286-7","volume":"68","author":"LF Cohen","year":"1980","unstructured":"Cohen LF, Balow JE, Magrath IT, et al: Acute tumor lysis syndrome: A review of 37 patients with Burkitt lymphoma. Am J Med 68: 486\u2013491, 1980","journal-title":"Am J Med"},{"key":"BF02893442_CR10","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.leukres.2004.09.004","volume":"29","author":"CY Liu","year":"2005","unstructured":"Liu CY, Sims-McCallum RP, Schiffer CA: A single dose of rasburicase is sufficient for the treatment of hyperuricemia in patients receiving chemotherapy. Leuk Res 29: 463\u2013465, 2005","journal-title":"Leuk Res"},{"key":"BF02893442_CR11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s00520-002-0435-3","volume":"11","author":"L Annemans","year":"2003","unstructured":"Annemans L, Moeremans K, Lamotte M, et al: Pan-European multicentre economic evaluation of recombinant urate oxidase (Rasburicase) in prevention and treatment of hyperuricemia and tumor lysis syndrome in haematological cancer patients. Support Care Cancer 11: 249\u2013257, 2003","journal-title":"Support Care Cancer"}],"container-title":["Pathology & Oncology Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02893442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF02893442\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02893442","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T10:39:09Z","timestamp":1589452749000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF02893442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["BF02893442"],"URL":"https:\/\/doi.org\/10.1007\/bf02893442","relation":{},"ISSN":["1219-4956","1532-2807"],"issn-type":[{"value":"1219-4956","type":"print"},{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3]]}}}